News

The Division of Intramural Research provides fundamental knowledge about the nature and behavior of living systems through basic, clinical, and population-based research.

A group of experts led by NICHD has proposed a new anatomic model of the ovary and recommended standardized nomenclature to describe its major features.

Learn about a collaboration between NICHD and Howard University.

NICHD researchers conducting a clinical study of patients with a rare, fatal neurological disorder have partnered with basic scientists to find better ways to understand the disease, monitor its progression, and ultimately find treatments.

Eight years ago, NIH announced a collaboration with the Bill & Melinda Gates Foundation to develop solutions for a variety of global health challenges. Learn how NICHD research is supporting this goal.

The experimental drug TEMPOL prevents viral replication and reduces disease severity in a hamster model of COVID-19, according to a new study led by NICHD.

During a research career that spans four decades, NICHD’s Judith Kassis, Ph.D., has learned many lessons along the way. Learn about her story.

A multidimensional MRI method developed at NICHD can detect astrogliosis, a neuroinflammatory response that occurs in traumatic brain injury and many other neurological conditions, a new study suggests. Researchers had previously established that the multidimensional MRI strategy can identify diffuse axonal injury—a microscopic brain injury that, like astrogliosis, cannot be detected by conventional radiological methods.

Poverty, combined with other types of adversity in early childhood, is associated with greater chances of premature death in adulthood, compared to other adverse childhood experiences, according to a study of more than 46,000 people by researchers at the National Institutes of Health.

The Division of Intramural Research provides fundamental knowledge about the nature and behavior of living systems through basic, clinical, and population-based research.

Learn about an experimental male contracteptive gel called NES/T, which was developed in collaboration with NICHD and the Population Council.

NICHD’s Dr. Claire Le Pichon helps advance understanding of neuron injury and neurodegenerative diseases by embracing new technologies, collaborating with other researchers, and mentoring the next generation of scientists. Read about her career path.

Unlike other SARS-CoV-2 variants, the Delta variant can attach to copies of itself, forming larger aggregations, or clumps, of viral particles, suggests a study by scientists at the National Institutes of Health. The researchers theorize that this linking property may have played a role in the ability of the Delta variant to spread more rapidly than all the variants that preceded it.

The Division of Intramural Research provides fundamental knowledge about the nature and behavior of living systems through basic, clinical, and population-based research.

NICHD researchers are evaluating ovarian tissue cryopreservation as a potential option to preserve fertility among young girls with Turner syndrome and other rare conditions that compromise ovarian function. The team also aims to determine the causes of ovarian problems in these girls.

The Division of Intramural Research provides fundamental knowledge about the nature and behavior of living systems through basic, clinical, and population-based research.

Small NIH study contributes to understanding of COVID-19 during pregnancy.

Read about NICHD’s research findings and activities from 2021.

Dr. Grewal has been acting director of the division since February 2020.

Riluzole, a drug approved to treat amyotrophic lateral sclerosis (ALS), a disease affecting nerve cells controlling movement, could slow the gradual loss of a particular brain cell that occurs in Niemann-Pick disease type C1 (NPC1), a rare genetic disorder affecting children and adolescents, suggests a study in mice by scientists at the National Institutes of Health.